"Pneumovax 23" - vaccination against pneumococcal infection
Temporarily out of stock
Pneumococcal vaccine, polyvalent.
Manufacturer: Merck Sharp & Dohme Corp (USA)
Protects against diseases: a vaccine to prevent 23 types of pneumococcal infections.
Try on: children aged 2 years and older and adults over 50 years old with an increased risk of contracting pneumococcal infection.
Not included in the national vaccination calendar.
IMPORTANT: vaccinations with the Pneumovax 23 vaccine are not carried out in clinics
Advantages of the Pneumovax 23 vaccine:
- Vaccine against the 23 most common and invasive serotypes of Streptococcus pneumoniae.
- The vaccine is effective against pneumococcal serotypes that are the most common cause of antibiotic-resistant pneumococcal infections.
- A single vaccination is required.
- The introduction of the vaccine leads to the rapid appearance of specific antibodies, which after 3 weeks provide immunity to infection lasting 5-10 years.
- 57% protective effectiveness of vaccination against invasive infections caused by serotypes included in the vaccine in children over 6 years of age.
- Mild side effects.
special instructions
This vaccine is especially indicated for people who suffer from sickle cell anemia , as well as people with asplenia ; those who have recently had a splenectomy or people who are about to undergo a splenectomy.
It should be noted that if revaccination is carried out earlier than the required period, the person may experience severe local side effects after the injection.
Since there is a possibility of severe side effects (in particular, the Arthus phenomenon), before administering the drug, you need to evaluate the benefits of vaccination and take into account all contraindications.
If a person is receiving immunosuppressive treatment, the immune response to Pneumo 23 may be suppressed.
One dose of the vaccine provides effective protection.
Indications for vaccination "Pneumovax 23"
Increased risk of developing pneumococcal disease, which is one of the leading causes of death worldwide and one of the leading causes of pneumonia, bacteremia, meningitis and otitis media in children over 2 years of age and in adults over 50 years of age.
Indications
Vaccination Pneumo-23 is indicated:
- People over 65 years old;
- Patients whose body is weakened and are often hospitalized (patients with heart and respiratory failure, diabetes, bronchitis);
- People suffering from bad habits (alcohol abuse and smoking);
- Patients with reduced immunity (HIV-infected, oncology patients, patients with nephrotic syndrome, patients who have undergone or are about to undergo splenectomy, patients with sickle cell anemia, etc.);
- Children from 2 to 5 years old, often susceptible to colds;
- People who are constantly in a group (kindergartens, schools, nursing homes, various institutions).
Even if the patient has suffered a pneumococcal infection, this is not a contraindication to the use of the Pneumo-23 vaccine.
Repeated vaccination is recommended:
- Adult patients at risk who used the vaccine 5 years ago;
- Patients with a rapid decrease in pneumococcal antibody titers (with nephrotic syndrome, organ transplantation, renal failure);
- Children over 10 years of age who were vaccinated 5 years ago with diseases such as asplenia, sickle cell anemia and nephrotic syndrome.
Before vaccination, be sure to consult your doctor!
Scheme and method of administration of the vaccine "Pneumovax 23"
In order to identify contraindications, the doctor conducts a survey and examination of the vaccinated person on the day of vaccination with mandatory thermometry.
Vaccinations are performed once. The vaccine is administered subcutaneously into the outer surface of the upper third of the shoulder. A single dose for all ages is 0.5 ml.
A single booster dose of Pneumovax 23 is recommended for persons 2 years of age and older who are at greatest risk of serious pneumococcal infections and those whose anti-pneumococcal antibody levels may decline rapidly, provided that at least five years have passed since The first dose of pneumococcal vaccine was administered. In children 10 years of age and younger who are considered to be at high risk for severe pneumococcal infections, revaccination with Pneumovax 23 may be considered three years after the previous dose of the vaccine.
Vaccination Pneumo 23, instructions for use (Method and dosage)
The instructions for Pneumo 23 stipulate that the vaccine is used parenterally. This solution must be administered directly from the syringe in which the product is packaged by the manufacturer.
The drug is administered subcutaneously or intramuscularly. Please note that it cannot be administered intravenously.
It is imperative that this vaccine is administered in a specialized medical facility by a qualified specialist.
Before receiving a dose of the vaccine, the patient must be examined by a specialist. If a person has a feeling of general weakness, hyperthermia, or exacerbation of chronic diseases, vaccination should be postponed.
After the drug has been administered, the person must remain under the supervision of a specialist for 30 minutes. If he develops anaphylactoid reactions, the patient is given emergency treatment.
The general scheme for using the vaccine is determined by the doctor. As a rule, during the first vaccination, one dose (0.5 ml) of Pneumo 23 is administered.
Revaccination is advisable after at least three years. When revaccinating, a person should also receive one dose (0.5 ml) of the product.
The permissible interval (three years) between the administration of Pneumo 23 can be reduced for people who have an increased likelihood of developing pneumococcal infection, as well as for those who have recently received immunosuppressive therapy.
Compatibility with other vaccines
The pneumococcal vaccine Pneumovax 23 can be given at the same time as the flu vaccine (which is given in the other arm). Such administration does not lead to an increase in the frequency of side effects or a decrease in the intensity of the immune response to the administration of each of the vaccines.
The pneumococcal vaccine can be administered simultaneously (on the same day) with other vaccines (except for vaccines to prevent tuberculosis) in different parts of the body using different syringes.
The Pneumovax 23 vaccine can be administered no earlier than 4 weeks after Zostavax vaccination.
Advantages of the Pneumo-23 vaccine
- One dose of the vaccine is sufficient for vaccination.
- Immunity lasts for 3-5 years.
- The Pneumo-23 vaccine is absolutely safe for humans.
- Pneumo-23 is packaged in disposable syringes with 1 dose of vaccine per syringe. For a person of any age, the vaccination dose is 0.5 ml.
- The Pneumo-23 vaccine has been registered by most European countries.
- Data from foreign studies have shown the effectiveness of the Pneumo-23 vaccine against 90% of pneumococci that are insensitive to penicillin, as well as against 96% of pneumococci that cause various diseases.
- Data from Russian studies also show the high effectiveness of the Pneumo-23 vaccine for the prevention and reduction of acute respiratory infections by 2 times, bronchitis by 12 times, pneumonia by 6 times in comparison with unvaccinated people.
- Pneumo-23 is well compatible with other vaccines, with the exception of the tuberculosis vaccine.
Contraindications
Only a doctor can decide whether PNEUMOVAX 23 is suitable for vaccination
Pneumovax 23 is contraindicated if there is a history of an allergic reaction to any component of the vaccine.
Vaccination with Pneumovax 23 is contraindicated in the following cases:
- Hypersensitivity to any component of the vaccine, including neomycin; symptoms of hypersensitivity to previous vaccine administration.
- Acute infectious and non-infectious diseases, exacerbation of chronic diseases are temporary contraindications for vaccinations, except in cases where, in the opinion of a doctor, delaying vaccination entails an even greater risk.
- Vaccination during chemotherapy or radiation therapy should be avoided.
Composition and use of the vaccine Pneumovax 23
The drug Pneumovax 23 is produced in Holland. Its release form is a disposable syringe with one dose of vaccine, the volume of which is 0.5 ml.
This dose is sufficient for one vaccination, regardless of the person’s age (from 2 years). The composition of the drug (polysaccharides and buffer-phenolic solution) ensures activation of immunity aimed at 23 types of pneumococcus.
How do you prepare for the Pneumovax 23 vaccination? Vaccination is carried out after an examination by a doctor, who first assesses your condition and health indicators and determines the need to administer the drug. No special preparation is required before the injection, but experts do not recommend administering the vaccine on an empty stomach or after heavy physical exertion.
After administering the vaccine, it is not advisable to take a bath, do cosmetic procedures or massage the limb where the vaccine was administered. The location of the vaccine is the shoulder or thigh, at the doctor’s choice. The vaccine is administered intramuscularly or subcutaneously.
The drug can be given simultaneously with other vaccinations, for example with DTP or the flu vaccine. The exception is the BCG vaccine. After the vaccine is administered, immunity develops at least a month later, which should be taken into account when determining the timing of vaccination.
How to help your young child feel comfortable during vaccinations
Vaccination works better when the baby is calm and not afraid. To avoid scaring your child, try the following:
- Distract and calm your baby, hug him, talk softly to him
- Be calm, confident, smile.
- Maintain eye contact with your child.
- Communicate with your child, show that you are nearby and everything is fine.
- Let your child hold a favorite toy or blanket.
- Ask your doctor if you can hold your baby on your lap and gently rub his back during vaccination.
- Be sure to praise your child after vaccination, tell him how great he is and how proud you are of him. Support your baby, even if he couldn't help but cry.
Indications and contraindications for the Pneumovax 23 vaccine
Pneumovax 23 is not a mandatory vaccine, so vaccination is carried out at will or for medical reasons. Vaccination is indicated:
- patients over 2 years old;
- patients who have been in specialized medical institutions for a long time;
- people under the age of 65 with at least one chronic disease of the kidneys, bronchi and lungs, heart and blood vessels;
- smokers and alcoholics;
- patients suffering from cirrhosis or hepatitis;
- for diabetes mellitus;
- in case of any type of immunodeficiency;
- people whose spleen has been removed;
- frequently ill children under 5 years of age; children with anemia.
Contraindications for vaccination can be complete or relative. The vaccine should not be administered if you are allergic to any component of the drug.
It is not recommended to use Pneumovax 23 at high temperatures, acute and chronic diseases during exacerbation, and the first two trimesters of pregnancy.
If the vaccination is given for prophylactic purposes, the drug is administered once, which provides protection against infection for a 5-year period.
Revaccination with Pneumovax 23 is carried out after 3–5 years, which depends on the patient’s health condition and the doctor’s decision.
